Novavax Global Commercial Operations and COVID-19 Vaccine Update

Novavax investment highlights novavax Fully integrated commercial-stage biotechnology company COVID-19 vaccine positioned to gain share in long-term market Protein-based technology provides vaccine choice ☑ Manufacturing and commercial network Proprietary Matrix-MTM adjuvant differentiates pipeline Positioned for long-term value creation through commercial execution and pipeline development © 2023 NOVAVAX. All rights reserved. 4

View entire presentation